During the past decade, Matrix Institute on Addictions conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Matrix Institute on Addictions" #1 collaborator was "University of Texas" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Matrix Institute on Addictions" are "Amphetamine-Related Disorders" (2 trials), "Methamphetamine" (1 trials) and "Substance-Related Disorders" (1 trials). Many other conditions were trialed in "Matrix Institute on Addictions" in a lesser frequency.

Most popular intervention types in "Matrix Institute on Addictions" are "Drug" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Behavior Therapy" (1 trials), "Bupropion" (1 trials), "Ondansetron" (1 trials), "Placebo Oral Tablet" (1 trials) and "Topiramate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Matrix Institute on Addictions" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Matrix Institute on Addictions". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Matrix Institute on Addictions, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Matrix Institute on Addictions, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".